Advocate Leader Resource Bank

Advocate Leaders Program

• • OCRA Advocate Leaders Manual 2025

• • OCRA Advocate Leaders Toolkit 2025
  • Social Media Toolkit

• • Basecamp Training Videos

Advocacy Day

• • OCRA Spring Advocacy Day Training – 3/2022

• • OCRA Spring Advocacy Day Training PowerPoint – 3/2024

Ovarian Cancer Awareness Month

• • Ovarian Cancer Awareness Month (OCAM) Toolkit (Updated 3/2024)

Federal Budget Process and Federal Programs

• • The Federal Budget Process Explained

• • Ovarian Cancer Research Program (OCRP) Background

Passing Legislation

• • How Legislation is Passed in the Senate

• • How Legislation is Passed in the House of Representatives

• • How the House and Senate Settle Legislative Differences

• • Guide to Reading a Legislative Measure

State Level Government

• • State Legislators: Who They Are and How to Work with Them

Structure of Congress

• • Congressional Committees and Federal Agencies of Interest to OCRA

• • Roles and Responsibilities of Selected Government Leadership Positions

• • Helpful Terms for Policy and Advocacy

• • Congress.gov Help Center

Your Representatives

• • How to Find Who Represents You at the Federal, State, and Local Level

• • Building Relationships with Your Representatives

• • How to Conduct an In-Person Meeting with Your Representatives

Tracking Legislation

• • Tracking Legislation at the Federal Level

• • Tracking Lesiglation at the State Level

Policy and Advocacy Writing

• • Resources for Writing Letters to the Editor

• • Resources for Writing Op-Eds

• • Resources for Writing Press Releases

Health Disparities

• • CMS Framework for Health Equity

Financial Toxicity and Copay Accumulators

• • Financial Toxicity and Cancer Treatment – from NCI

• • HELP Copays Act

• • Discriminatory Copay Policies Undermine Coverage for People with Chronic Illness – from The AIDS Institute

• • Lawsuit Challenges Federal Copay Accumulator Policy – from Health Affairs

Clinical Trials

• • Recruitment to Cancer Clinical Trials: Challenges and Strategies – from NCI

• • Overview of the DIVERSE Trials Act – from ACS CAN

Genetic Testing

• • Reducing Hereditary Cancer Act

Health Disparities

• • Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study

Genetic Testing

• • Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women with Breast Cancer

Early Detection

• • UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Study

General Ovarian Cancer Research

• • Ovarian Cancers: Evolving Paradigms in Research and Care